Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vanda Pharmaceuticals Inc. - Common Stock (NQ:VNDA)

4.295 -0.115 (-2.61%)
Streaming Delayed Price Updated: 12:22 PM EST, Nov 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 299,643
Open 4.400
Bid (Size) 4.290 (1,200)
Ask (Size) 4.300 (600)
Prev. Close 4.410
Today's Range 4.270 - 4.400
52wk Range 3.809 - 5.700
Shares Outstanding 55,638,166
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
This Docebo Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Wednesday
 
Via Benzinga
This Trex Company Analyst Turns Bearish; Here Are Top 5 Downgrades For Wednesday
 
Via Benzinga

Performance

YTD
-10.9%
-10.9%
1 Month
-19.2%
-19.2%
3 Month
+2.3%
+2.3%
6 Month
+1.8%
+1.8%
1 Year
-12.2%
-12.2%

More News

Read More
VANDA PHARMACEUTICALS INC (NASDAQ:VNDA) Reports Q3 2025 Earnings Miss on Revenue, Beat on EPS
Via Chartmill
Topics Earnings
Earnings Scheduled For October 29, 2025
Via Benzinga
Jim Cramer Calls Cameco A Good Company, Recommends Buying This Financial Stock
Via Benzinga
Vanda Pharma Stock Rockets 9% After Federal Appeals Court Sets Aside FDA Action: Retail Expects Stock To Cross $5-Mark
Via Stocktwits
Earnings Scheduled For July 31, 2025
Via Benzinga
Earnings Scheduled For May 7, 2025
Via Benzinga
A Glimpse of Vanda Pharma's Earnings Potential
Via Benzinga
AnaptysBio Charts Path To Split Into Two Public Companies By 2026
Via Benzinga
Retail Buzz Builds As Vanda Urges FDA Chief To Revisit Hetlioz Generics Decision — Alleges “Bias Toward Approvals”
Via Stocktwits
Topics Retirement
Vanda (VNDA) Q2 Revenue Rises 4%
Via The Motley Fool
Topics Intellectual Property
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
The Analyst Verdict: Vanda Pharma In The Eyes Of 5 Experts
Via Benzinga
Earnings Scheduled For February 13, 2025
Via Benzinga
A Glimpse Into The Expert Outlook On Vanda Pharma Through 4 Analysts
Via Benzinga
Forecasting The Future: 5 Analyst Projections For Vanda Pharmaceuticals
Via Benzinga
Vanda Pharmaceuticals and Anaptys Announce Exclusive Global License Agreement for Vanda to Develop and Commercialize Imsidolimab, an IL-36R Antagonist
From AnaptysBio, Inc.
Via GlobeNewswire
FDA Unveils Grounds For Rejecting Vanda Pharmaceuticals Stomach Paralysis Candidate
Via Benzinga
Glancy Prongay & Murray LLP Announces Investigation of Vanda Pharmaceuticals Inc.
From Glancy Prongay & Murray LLP
Via Business Wire
Over 200% Stock Upside - Vanda Pharmaceuticals Undervalued With Robust Portfolio And Pipeline: Analyst
Via Benzinga
Why Vanda Pharmaceuticals Stock Sank by Nearly 6% Today
Via The Motley Fool
FDA Strikes Off Vanda Pharmaceuticals' Tradipitant For Stomach Paralysis, Asks For Additional Studies
Via Benzinga
Revolutionary Magnetic Therapy Could Speed Up Bipolar Treatment
Via PressReach
What's Going On With Vanda Pharmaceuticals Shares Today?
Via Benzinga

Frequently Asked Questions

Is Vanda Pharmaceuticals Inc. - Common Stock publicly traded?
Yes, Vanda Pharmaceuticals Inc. - Common Stock is publicly traded.
What exchange does Vanda Pharmaceuticals Inc. - Common Stock trade on?
Vanda Pharmaceuticals Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Vanda Pharmaceuticals Inc. - Common Stock?
The ticker symbol for Vanda Pharmaceuticals Inc. - Common Stock is VNDA on the Nasdaq Stock Market
What is the current price of Vanda Pharmaceuticals Inc. - Common Stock?
The current price of Vanda Pharmaceuticals Inc. - Common Stock is 4.295
When was Vanda Pharmaceuticals Inc. - Common Stock last traded?
The last trade of Vanda Pharmaceuticals Inc. - Common Stock was at 11/07/25 12:22 PM ET
What is the market capitalization of Vanda Pharmaceuticals Inc. - Common Stock?
The market capitalization of Vanda Pharmaceuticals Inc. - Common Stock is 238.97M
How many shares of Vanda Pharmaceuticals Inc. - Common Stock are outstanding?
Vanda Pharmaceuticals Inc. - Common Stock has 239M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.